New cavity marking technique for breast cancer surgery and radiation
Part of Cancer, Skin clinical trials.
This trial tests a new way to mark the area where breast cancer is removed during lumpectomy with oncoplastic reconstruction. The goal is to make follow-up radiation more precise and reduce the need for additional surgeries.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with non-invasive (DCIS) or invasive breast cancer that has not spread far.
- You are planning to have or have had breast conservation surgery (lumpectomy) with oncoplastic reconstruction and cavity marking.
- You are in fairly good health (ECOG score 0-1).
- If you can become pregnant, you must use effective birth control during the surgery and radiation phases.
- You have not had prior breast surgery on the same side that left surgical clips.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to predict whether radiation after lumpectomy will help women with DCIS, a very early form of breast cancer. You'll take a test called DCISionRT that looks at your cancer's biology, then you'll be randomly assigned to either get radiation or not, so doctors can learn who really needs it.
This study tests whether placing a tiny radioactive seed at the tumor site during chemotherapy before surgery can help improve how completely the tumor is removed and possibly improve long-term outcomes. It's a way to mark the exact tumor spot so the surgeon can remove it precisely after chemo shrinks it.
This study records details about radiation delivered while your surgery is happening for certain early breast cancers or pre-cancers. It may help doctors better understand who benefits most from this “intra-operative” radiation approach.
This trial tests a one-time radiation treatment given directly to the area where your breast cancer was removed. It aims to reduce the need for multiple radiation sessions and may be an option for certain patients with early-stage breast cancer.
This trial tests a shorter, focused type of radiation (APBI using SBRT) after lumpectomy for certain early breast cancers. It may help by targeting only the part of the breast where the tumor was, rather than treating the whole breast, while keeping safety and cancer control in mind.
This study tests whether small disappearing ink marks can be used to guide daily radiation treatments for breast cancer. It may help make radiation more precise and comfortable.
Hear when a new Ductal Carcinoma in Situ trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.